Valuation: Yuhan Corporation

Market Cap 5,482B 3.81B 3.32B 3.09B 2.83B 5.35B 364B 5.43B 36.38B 14.28B 181B 14.32B 14.01B 608B P/E 2026 *
36.9x
P/E 2027 * 26.2x
Enterprise Value 5.38B 3.75M 3.26M 3.03M 2.78M 5.25M 358M 5.34M 35.72M 14.02M 178M 14.07M 13.76M 597M EV / Sales 2026 *
2.28x
EV / Sales 2027 * 2.06x
Free-Float
64.28%
Yield 2026 *
0.76%
Yield 2027 * 0.77%
1 day-0.68%
1 week-1.87%
1 month+4.85%
3 months-19.76%
6 months-29.73%
Current year-34.61%
1 week 68,500
Extreme 68500
75,200
1 month 66,200
Extreme 66200
77,100
Current year 65,000
Extreme 65000
115,900
1 year 65,000
Extreme 65000
129,200
3 years 52,285.71
Extreme 52285.7143
166,900
5 years 47,571.43
Extreme 47571.4286
166,900
10 years 24,550.49
Extreme 24550.4865
166,900
Manager TitleAgeSince
Chief Executive Officer 71 2021-03-18
Director of Finance/CFO 58 -
President 67 2024-03-14
Director TitleAgeSince
Chairman 74 2021-03-18
Director/Board Member 71 2015-03-19
Director/Board Member 62 2020-02-29
Date Insider Type Main position Quantity % Market Cap.
6/30/25 Buy

Chairperson

200 0.0002%
6/25/25 Buy

Chief Executive Officer

720 0.0009%
6/24/25 Buy 231 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
-0.68%-1.87%-34.78%+6.01% 3.81B
+0.32%-0.66%+64.21%+23.18% 322B
+0.21%+2.87%+33.60%-10.00% 71.6B
-0.91%+0.74%+39.85%+92.63% 9.79B
-1.86%-5.79%-2.24%-7.83% 8.39B
+1.80%-1.99%-15.78%-13.19% 4.3B
+3.08%-1.41%-12.94%+15.81% 3.58B
-2.15%-3.40%+25.70%+41.55% 2.59B
+0.85%+9.88%-0.25%-3.21% 2.25B
-.--%+4.37%-22.39%-14.67% 1.76B
Average +0.10%-0.10%+7.50%+13.03% 42.96B
Weighted average by Cap. +0.31%-0.08%+54.01%+17.87%

Financials

2026 *2027 *
Net sales 2,357B 1.64B 1.43B 1.33B 1.22B 2.3B 157B 2.34B 15.64B 6.14B 77.93B 6.16B 6.02B 261B 2,572B 1.79B 1.56B 1.45B 1.33B 2.51B 171B 2.55B 17.06B 6.7B 85.03B 6.72B 6.57B 285B
Net income 157B 109M 94.9M 88.33M 81.1M 153M 10.42B 156M 1.04B 409M 5.19B 410M 401M 17.4B 211B 147M 128M 119M 109M 206M 14.01B 209M 1.4B 549M 6.98B 551M 539M 23.39B
Net Debt -98.59B -68.59M -59.63M -55.5M -50.96M -96.23M -6.55B -97.72M -654M -257M -3.26B -258M -252M -10.93B -175B -122M -106M -98.7M -90.62M -171M -11.64B -174M -1.16B -457M -5.8B -458M -448M -19.44B
Logo Yuhan Corporation
Yuhan Corp is a Korea-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through three segments. The Pharmaceutical Business segment manufactures and sells non-prescription drugs, such as analgesics, anti-inflammatory drugs, probiotics, nutritional supplements, and wound-healing agents, as well as prescription drugs, including treatments for diabetes, hyperlipidemia, hypertension, hepatitis, acquired immunodeficiency syndrome (AIDS), bone marrow cancer, cough suppressants, and breast cancer. The Overseas Business segment engages in the export of AIDS treatment intermediates. The Healthcare Business segment provides household goods, such as bleach. Additionally, the Company sells licenses. The Company sells its products in both domestic and overseas markets.
Employees
2,087
Date Price Change Volume
26-07-31 ₩73,500.00 -0.68% 321,744
26-07-30 ₩74,000.00 +5.26% 404,762
26-07-29 ₩70,300.00 -0.57% 464,533
26-07-28 ₩70,700.00 -1.81% 229,612
26-07-27 ₩72,000.00 -3.87% 202,403
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
73,500.00KRW
Average target price
125,611.11KRW
Spread / Average Target
+70.90%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A000100 Stock